drugset / Trial / NCT01387672

Nitrates and Bone Turnover; Nitrates and Bone Turnover Bisphosphonate Sub-Study

NCT01387672

RandomizedParallel-groupOpen-labelPrevention

Summary

Purpose: NABT: To compare five widely available nitrate formulations: (1) 15 of nitroglycerin (NTG) ointment, (2) 0.3 mg and (3) 0.6 mg of sublingual NTG, (4) 20 mg of isosorbide mononitrate (an oral tablet), and (5) 160 mg of glycerol trinitrate (a patch), for their efficacy on markers of bone formation and resorption and for the incidence and severity of headache they cause. Hypothesis: There is one ideal nitrate preparation which balances the clinical efficacy in bone remodeling against the common side effect of headache. NABT-B: To determine if nitrates affect markers of bone formation (serum BALP and P1NP) and resorption (serum CTX and urine NTX) in women who have recently discontinued treatment with alendronate, risedronate or zoledronate.

Timeline

Start
2011-09
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isosorbide Mononitrate Other / unclassified 20 mg Oral
Comparator Nitroglycerin Unknown 0.3 mg Topical
Comparator Nitroglycerin Unknown 0.6 mg Topical
Comparator Nitroglycerin Unknown 15 mg Topical
Comparator Nitroglycerin Unknown 160 mg Topical

Indications